Devices and Methods for Extracorporeal Ablation of Circulating Cells
AssigneeNanospectra Biosciences, Inc.
InventorsMartin Korbling, J. Donald Payne, Christopher L. Coleman, Jon A. Schwartz
Life of this patent
Estimating the term…
Loading patent…
AssigneeNanospectra Biosciences, Inc.
InventorsMartin Korbling, J. Donald Payne, Christopher L. Coleman, Jon A. Schwartz
Estimating the term…
Methods and devices are provided for the extracorporeal ablation of target cells circulating in blood of an organism. Exogenous material introduced into the blood preferentially associates with target cells (e.g. cancer cells, bacteria, viruses) in the blood. An extracorporeal continuous flow pathway accesses the patient's blood to apply an external energy source to the blood at an ex vivo ablation device in a portion of the extracorporeal continuous flow pathway. The exogenous material interact with the applied energy so as to result in the damage or death of the target cells. The blood is then returned to the body in a continuous-flow pattern. By applying the energy while the blood is in the ex vivo ablation device, shielding of the target cells by the body is reduced and detrimental effects on the organs and tissues of the body are avoided or mitigated.
A method for the extracorporeal ablation of target cells circulating in blood of an organism, said method comprising:
A device for the extracorporeal ablation of target cells circulating in blood comprising:
A system for the extracorporeal ablation of targets within blood, said system comprising:
A system for the extracorporeal ablation of targets within blood, said system comprising:
A method for the extracorporeal ablation of target cells circulating in the blood of a biological body, said method comprising:
A method for the ablation of target cells circulating in the blood of a biological body, said method comprising:
Dependencies are inferred from the claim text.